Though prescribing climate-friendly dry powder inhalers is environmentally sound, some experts warn certain patients may be ...

According to Coherent Market Insights, the global respiratory inhalers market size is estimated to be valued at USD 33.11 billion in 2024 and is expected to surpass USD 49.10 billion by 2031, growing ...

In a bid to improve the pharma sector’s drive to cut down greenhouse emissions, several companies are advancing dry powder inhalers (DPIs) for respiratory conditions that are more eco-friendly ...

Conventionally, inhaled drugs have been used to deliver medicines targeted at the most widespread respiratory diseases – specifically, chronic obstructive pulmonary disease (COPD) and asthma.

Controller medications, also known as daily maintenance medications, are a critical tool for managing asthma — reducing daily ...

The dry powder inhaler market is projected to be worth USD 20.83 billion in 2024. The market is likely to reach USD 29.95 ...

Lupin Healthcare UK Ltd has announced plans to reformulate its pMDI inhalers with a near-zero global warming potential ...

“This is just the beginning of our journey to transform respiratory care ... the global market for smart inhaler devices that enable real-time tracking of medication usage, provide feedback ...